» Articles » PMID: 18845758

CTLA-4 Control over Foxp3+ Regulatory T Cell Function

Overview
Journal Science
Specialty Science
Date 2008 Oct 11
PMID 18845758
Citations 1436
Authors
Affiliations
Soon will be listed here.
Abstract

Naturally occurring Foxp3+CD4+ regulatory T cells (Tregs) are essential for maintaining immunological self-tolerance and immune homeostasis. Here, we show that a specific deficiency of cytotoxic T lymphocyte antigen 4 (CTLA-4) in Tregs results in spontaneous development of systemic lymphoproliferation, fatal T cell-mediated autoimmune disease, and hyperproduction of immunoglobulin E in mice, and it also produces potent tumor immunity. Treg-specific CTLA-4 deficiency impairs in vivo and in vitro suppressive function of Tregs-in particular, Treg-mediated down-regulation of CD80 and CD86 expression on dendritic cells. Thus, natural Tregs may critically require CTLA-4 to suppress immune responses by affecting the potency of antigen-presenting cells to activate other T cells.

Citing Articles

Podocyturia an emerging biomarker for kidney injury.

Hanna C, Etry H, Ibrahim M, Khalife L, Bahous S, Faour W BMC Nephrol. 2025; 26(1):118.

PMID: 40045253 PMC: 11884025. DOI: 10.1186/s12882-025-04039-w.


Tumor microenvironment as a novel therapeutic target for lymphoid leukemias.

Mousavi S, Nouri S, Sadeghipour A, Atashi A Ann Hematol. 2025; .

PMID: 39994019 DOI: 10.1007/s00277-025-06237-w.


Immune Checkpoints Are New Therapeutic Targets in Regulating Cardio-, and Cerebro-Vascular Diseases and CD4Foxp3 Regulatory T Cell Immunosuppression.

Shao Y, Yang W, Nanayakkara G, Saaoud F, Ben Issa M, Xu K Int J Drug Discov Pharm. 2025; 3(4).

PMID: 39926714 PMC: 11804271. DOI: 10.53941/ijddp.2024.100022.


Hepatocellular carcinoma: signaling pathways and therapeutic advances.

Zheng J, Wang S, Xia L, Sun Z, Chan K, Bernards R Signal Transduct Target Ther. 2025; 10(1):35.

PMID: 39915447 PMC: 11802921. DOI: 10.1038/s41392-024-02075-w.


Multiple machine learning-based integrations of multi-omics data to identify molecular subtypes and construct a prognostic model for HNSCC.

Luo X, Li C, Qin G Hereditas. 2025; 162(1):17.

PMID: 39910672 PMC: 11800565. DOI: 10.1186/s41065-025-00380-0.